Pulmonary hypertension associated with connective tissue disease

This publication has 82 references indexed in Scilit:

• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
  Annals of the Rheumatic Diseases, 2001
• Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange: CASE REPORT
  Scandinavian Journal of Rheumatology, 2000
• Raynaud's phenomenon and scleroderma dysregulated neuroendothelial control of vascular tone
  Arthritis & Rheumatism, 1995
• Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.
  Annals of the Rheumatic Diseases, 1993
• Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease
  The American Journal of Cardiology, 1991
• Platelet serotonin in systemic sclerosis.
  Annals of the Rheumatic Diseases, 1989
• Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon
  International Journal of Cardiology, 1988
• Sustained benefit of verapamil in pulmonary hypertension with progressive systemic sclerosis
  American Heart Journal, 1985
• Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease
  American Heart Journal, 1982